Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization 21Principal Investigators and Coordinators of the International Collaborative Post-Marketing Surveillance of Norplant: H. Akhter, Bangladesh Institute of Research for Promotion of Essential and Reproductive Health Technologies, Dhaka, Bangladesh; Gu Su-juan, Beijing Municipal Research Institute for Family Planning, Beijing, People’s Republic of China; Du Ming-kun, Shanghai Medical University, Shanghai, People’s Republic of China; S. Diaz, Instituto Chileno de Medicina Reproductiva, Santiago, Chile; I. Campodonico, Hospital Clinico San Borja-Arriaran, Santiago, Chile; G. Ojeda, Profamilia, Bogota, Colombia; E.O. Hassan, Egyptian Fertility Care Society, Cairo, Egypt; B. Affandi, University of Indonesia, Jakarta, Indonesia; S. Basnayake, The Family Planning Association of Sri Lanka, Colombo, Sri Lanka; Suporn Koetsawang, Siriraj Hospital, Bangkok, Thailand; J. Gill, The Population Council, Bangkok, Thail
| Autor: | Meirik, Olav, Farley, Timothy M.M, Sivin, Irving |
|---|---|
| Zdroj: | Obstetrics and Gynecology; January 2001, Vol. 97 Issue: 4 p539-547, 9p |
| Abstrakt: | Objective: To evaluate safety and efficacy of levonorgestrel-releasing contraceptive implants (Norplant; Leiras Oy, Turku, Finland) in developing countries. |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|